Get the app!
Back to Trades
Total Value
$109.6K
Filing Date
Mar 3, 2026
1 transactions

Trade Summary

On Feb 28, 2026, DeFrancesco Lisa, SVP, IR and Corp Comm, reported $109.6K of LEXICON PHARMACEUTICALS, INC. (LXRX) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $1.47. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Ticker Symbol
LXRX
CIK
0001062822

Insider Information

Role
SVP, IR and Corp Comm
Location
SPRING, TX

Filing Details

Filing Date
Mar 3, 2026
Transaction Date
Feb 28, 2026
Accession Number
0001062822-26-000037
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 28, 2026Common Stock24,674Exercise
Feb 28, 2026Common Stock128,190Exercise
Feb 28, 2026Common Stock74,572$1.47Tax Withholding$109.6K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Feb 28, 2026LXRX derivative24,674Exercise
Feb 28, 2026LXRX derivative128,190Exercise

Want live alerts when DeFrancesco Lisa trades again?

Download Insider Trades to track LXRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)Each restricted stock unit represents a contingent right to receive one share of common stock.
  2. (F2)Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  3. (F3)Each restricted stock unit represents a contingent right to receive one share of common stock.
  4. (F4)Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.